nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesalazine—PPARG—metabolic syndrome X	0.497	0.703	CbGaD
Mesalazine—PTGS2—metabolic syndrome X	0.21	0.297	CbGaD
Mesalazine—PPARG—brown adipose tissue—metabolic syndrome X	0.00924	0.122	CbGeAlD
Mesalazine—MPO—artery—metabolic syndrome X	0.00458	0.0607	CbGeAlD
Mesalazine—PPARG—artery—metabolic syndrome X	0.00407	0.0538	CbGeAlD
Mesalazine—MPO—endothelium—metabolic syndrome X	0.00387	0.0512	CbGeAlD
Mesalazine—MPO—blood vessel—metabolic syndrome X	0.00357	0.0473	CbGeAlD
Mesalazine—PPARG—endothelium—metabolic syndrome X	0.00344	0.0455	CbGeAlD
Mesalazine—CHUK—cardiovascular system—metabolic syndrome X	0.00334	0.0442	CbGeAlD
Mesalazine—PPARG—blood vessel—metabolic syndrome X	0.00317	0.0419	CbGeAlD
Mesalazine—CHUK—adipose tissue—metabolic syndrome X	0.00295	0.039	CbGeAlD
Mesalazine—Abdominal bloating—Metformin—metabolic syndrome X	0.00261	0.0484	CcSEcCtD
Mesalazine—IKBKB—cardiovascular system—metabolic syndrome X	0.00227	0.0301	CbGeAlD
Mesalazine—PTGS1—artery—metabolic syndrome X	0.00217	0.0288	CbGeAlD
Mesalazine—Gastrointestinal symptom NOS—Metformin—metabolic syndrome X	0.00211	0.0392	CcSEcCtD
Mesalazine—PTGS2—artery—metabolic syndrome X	0.00208	0.0275	CbGeAlD
Mesalazine—CHUK—liver—metabolic syndrome X	0.00207	0.0274	CbGeAlD
Mesalazine—IKBKB—adipose tissue—metabolic syndrome X	0.002	0.0265	CbGeAlD
Mesalazine—Nail disorder—Metformin—metabolic syndrome X	0.00191	0.0356	CcSEcCtD
Mesalazine—Upset stomach—Metformin—metabolic syndrome X	0.00189	0.0352	CcSEcCtD
Mesalazine—ALOX5—cardiovascular system—metabolic syndrome X	0.00188	0.0249	CbGeAlD
Mesalazine—PTGS1—endothelium—metabolic syndrome X	0.00184	0.0243	CbGeAlD
Mesalazine—PTGS2—endothelium—metabolic syndrome X	0.00176	0.0232	CbGeAlD
Mesalazine—PTGS1—blood vessel—metabolic syndrome X	0.00169	0.0224	CbGeAlD
Mesalazine—ALOX5—adipose tissue—metabolic syndrome X	0.00166	0.022	CbGeAlD
Mesalazine—PTGS2—blood vessel—metabolic syndrome X	0.00162	0.0214	CbGeAlD
Mesalazine—MPO—cardiovascular system—metabolic syndrome X	0.00159	0.0211	CbGeAlD
Mesalazine—MPO—kidney—metabolic syndrome X	0.00156	0.0206	CbGeAlD
Mesalazine—Rhinorrhoea—Metformin—metabolic syndrome X	0.00153	0.0285	CcSEcCtD
Mesalazine—Blood disorder—Metformin—metabolic syndrome X	0.00148	0.0276	CcSEcCtD
Mesalazine—PPARG—cardiovascular system—metabolic syndrome X	0.00141	0.0187	CbGeAlD
Mesalazine—IKBKB—liver—metabolic syndrome X	0.00141	0.0186	CbGeAlD
Mesalazine—PPARG—kidney—metabolic syndrome X	0.00138	0.0183	CbGeAlD
Mesalazine—PPARG—adipose tissue—metabolic syndrome X	0.00125	0.0165	CbGeAlD
Mesalazine—Olsalazine—PPARG—metabolic syndrome X	0.00119	0.278	CrCbGaD
Mesalazine—ALOX5—liver—metabolic syndrome X	0.00116	0.0154	CbGeAlD
Mesalazine—Neuropathy—Metformin—metabolic syndrome X	0.00116	0.0217	CcSEcCtD
Mesalazine—Ear pain—Metformin—metabolic syndrome X	0.00106	0.0196	CcSEcCtD
Mesalazine—MPO—liver—metabolic syndrome X	0.000985	0.013	CbGeAlD
Mesalazine—Renal impairment—Metformin—metabolic syndrome X	0.000946	0.0176	CcSEcCtD
Mesalazine—Lethargy—Metformin—metabolic syndrome X	0.000919	0.0171	CcSEcCtD
Mesalazine—Migraine—Metformin—metabolic syndrome X	0.000886	0.0165	CcSEcCtD
Mesalazine—PPARG—liver—metabolic syndrome X	0.000874	0.0116	CbGeAlD
Mesalazine—Liver function test abnormal—Metformin—metabolic syndrome X	0.000831	0.0155	CcSEcCtD
Mesalazine—Abdominal pain upper—Metformin—metabolic syndrome X	0.000822	0.0153	CcSEcCtD
Mesalazine—Breast disorder—Metformin—metabolic syndrome X	0.000814	0.0151	CcSEcCtD
Mesalazine—Cramp muscle—Metformin—metabolic syndrome X	0.000811	0.0151	CcSEcCtD
Mesalazine—Nasopharyngitis—Metformin—metabolic syndrome X	0.000805	0.015	CcSEcCtD
Mesalazine—Abdominal distension—Metformin—metabolic syndrome X	0.000783	0.0146	CcSEcCtD
Mesalazine—Influenza—Metformin—metabolic syndrome X	0.000778	0.0145	CcSEcCtD
Mesalazine—Pancreatitis—Metformin—metabolic syndrome X	0.000763	0.0142	CcSEcCtD
Mesalazine—Angina pectoris—Metformin—metabolic syndrome X	0.000758	0.0141	CcSEcCtD
Mesalazine—PTGS1—cardiovascular system—metabolic syndrome X	0.000756	0.01	CbGeAlD
Mesalazine—Abdominal discomfort—Metformin—metabolic syndrome X	0.000746	0.0139	CcSEcCtD
Mesalazine—PTGS1—kidney—metabolic syndrome X	0.00074	0.00979	CbGeAlD
Mesalazine—Salicylate-sodium—PTGS2—metabolic syndrome X	0.000736	0.171	CrCbGaD
Mesalazine—Neutropenia—Metformin—metabolic syndrome X	0.000728	0.0135	CcSEcCtD
Mesalazine—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.000723	0.0134	CcSEcCtD
Mesalazine—PTGS2—cardiovascular system—metabolic syndrome X	0.000722	0.00956	CbGeAlD
Mesalazine—PTGS2—kidney—metabolic syndrome X	0.000707	0.00935	CbGeAlD
Mesalazine—Infestation—Metformin—metabolic syndrome X	0.000694	0.0129	CcSEcCtD
Mesalazine—Infestation NOS—Metformin—metabolic syndrome X	0.000694	0.0129	CcSEcCtD
Mesalazine—Neuropathy peripheral—Metformin—metabolic syndrome X	0.00068	0.0126	CcSEcCtD
Mesalazine—PTGS1—adipose tissue—metabolic syndrome X	0.000667	0.00882	CbGeAlD
Mesalazine—Hepatobiliary disease—Metformin—metabolic syndrome X	0.000656	0.0122	CcSEcCtD
Mesalazine—PTGS2—adipose tissue—metabolic syndrome X	0.000637	0.00843	CbGeAlD
Mesalazine—Rhinitis—Metformin—metabolic syndrome X	0.000624	0.0116	CcSEcCtD
Mesalazine—Hepatitis—Metformin—metabolic syndrome X	0.000623	0.0116	CcSEcCtD
Mesalazine—Oedema peripheral—Metformin—metabolic syndrome X	0.000614	0.0114	CcSEcCtD
Mesalazine—Connective tissue disorder—Metformin—metabolic syndrome X	0.000612	0.0114	CcSEcCtD
Mesalazine—Eye disorder—Metformin—metabolic syndrome X	0.000582	0.0108	CcSEcCtD
Mesalazine—Cardiac disorder—Metformin—metabolic syndrome X	0.000578	0.0107	CcSEcCtD
Mesalazine—Angiopathy—Metformin—metabolic syndrome X	0.000565	0.0105	CcSEcCtD
Mesalazine—Immune system disorder—Metformin—metabolic syndrome X	0.000563	0.0105	CcSEcCtD
Mesalazine—Mediastinal disorder—Metformin—metabolic syndrome X	0.000561	0.0104	CcSEcCtD
Mesalazine—Chills—Metformin—metabolic syndrome X	0.000559	0.0104	CcSEcCtD
Mesalazine—Erythema—Metformin—metabolic syndrome X	0.000542	0.0101	CcSEcCtD
Mesalazine—Flatulence—Metformin—metabolic syndrome X	0.000534	0.00994	CcSEcCtD
Mesalazine—Dysgeusia—Metformin—metabolic syndrome X	0.000531	0.00987	CcSEcCtD
Mesalazine—Muscle spasms—Metformin—metabolic syndrome X	0.000521	0.00969	CcSEcCtD
Mesalazine—Vision blurred—Metformin—metabolic syndrome X	0.000511	0.0095	CcSEcCtD
Mesalazine—Tremor—Metformin—metabolic syndrome X	0.000508	0.00945	CcSEcCtD
Mesalazine—Olsalazine—PTGS2—metabolic syndrome X	0.000504	0.117	CrCbGaD
Mesalazine—Ill-defined disorder—Metformin—metabolic syndrome X	0.000503	0.00935	CcSEcCtD
Mesalazine—Malaise—Metformin—metabolic syndrome X	0.000489	0.00909	CcSEcCtD
Mesalazine—Syncope—Metformin—metabolic syndrome X	0.000486	0.00904	CcSEcCtD
Mesalazine—Palpitations—Metformin—metabolic syndrome X	0.000479	0.00891	CcSEcCtD
Mesalazine—Loss of consciousness—Metformin—metabolic syndrome X	0.000477	0.00886	CcSEcCtD
Mesalazine—Aminosalicylic Acid—PTGS2—metabolic syndrome X	0.000474	0.11	CrCbGaD
Mesalazine—Diflunisal—PTGS2—metabolic syndrome X	0.000474	0.11	CrCbGaD
Mesalazine—Hypertension—Metformin—metabolic syndrome X	0.000468	0.0087	CcSEcCtD
Mesalazine—Chest pain—Metformin—metabolic syndrome X	0.000462	0.00858	CcSEcCtD
Mesalazine—Myalgia—Metformin—metabolic syndrome X	0.000462	0.00858	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.000458	0.00852	CcSEcCtD
Mesalazine—Discomfort—Metformin—metabolic syndrome X	0.000456	0.00848	CcSEcCtD
Mesalazine—PTGS2—liver—metabolic syndrome X	0.000447	0.00591	CbGeAlD
Mesalazine—Oedema—Metformin—metabolic syndrome X	0.000443	0.00823	CcSEcCtD
Mesalazine—Infection—Metformin—metabolic syndrome X	0.00044	0.00817	CcSEcCtD
Mesalazine—Shock—Metformin—metabolic syndrome X	0.000435	0.0081	CcSEcCtD
Mesalazine—Nervous system disorder—Metformin—metabolic syndrome X	0.000434	0.00807	CcSEcCtD
Mesalazine—Thrombocytopenia—Metformin—metabolic syndrome X	0.000433	0.00806	CcSEcCtD
Mesalazine—Skin disorder—Metformin—metabolic syndrome X	0.00043	0.00799	CcSEcCtD
Mesalazine—Hyperhidrosis—Metformin—metabolic syndrome X	0.000428	0.00795	CcSEcCtD
Mesalazine—Diflunisal—ALB—metabolic syndrome X	0.000422	0.0982	CrCbGaD
Mesalazine—Anorexia—Metformin—metabolic syndrome X	0.000422	0.00784	CcSEcCtD
Mesalazine—Hypotension—Metformin—metabolic syndrome X	0.000413	0.00769	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000403	0.0075	CcSEcCtD
Mesalazine—Paraesthesia—Metformin—metabolic syndrome X	0.000397	0.00739	CcSEcCtD
Mesalazine—Dyspnoea—Metformin—metabolic syndrome X	0.000395	0.00734	CcSEcCtD
Mesalazine—Somnolence—Metformin—metabolic syndrome X	0.000393	0.00732	CcSEcCtD
Mesalazine—Dyspepsia—Metformin—metabolic syndrome X	0.00039	0.00724	CcSEcCtD
Mesalazine—Decreased appetite—Metformin—metabolic syndrome X	0.000385	0.00715	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000382	0.0071	CcSEcCtD
Mesalazine—Fatigue—Metformin—metabolic syndrome X	0.000382	0.00709	CcSEcCtD
Mesalazine—Constipation—Metformin—metabolic syndrome X	0.000378	0.00704	CcSEcCtD
Mesalazine—Feeling abnormal—Metformin—metabolic syndrome X	0.000365	0.00678	CcSEcCtD
Mesalazine—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000362	0.00673	CcSEcCtD
Mesalazine—Urticaria—Metformin—metabolic syndrome X	0.000352	0.00654	CcSEcCtD
Mesalazine—Abdominal pain—Metformin—metabolic syndrome X	0.00035	0.0065	CcSEcCtD
Mesalazine—Asthenia—Metformin—metabolic syndrome X	0.000317	0.0059	CcSEcCtD
Mesalazine—Pruritus—Metformin—metabolic syndrome X	0.000313	0.00582	CcSEcCtD
Mesalazine—Diarrhoea—Metformin—metabolic syndrome X	0.000303	0.00563	CcSEcCtD
Mesalazine—Dizziness—Metformin—metabolic syndrome X	0.000293	0.00544	CcSEcCtD
Mesalazine—Vomiting—Metformin—metabolic syndrome X	0.000281	0.00523	CcSEcCtD
Mesalazine—Rash—Metformin—metabolic syndrome X	0.000279	0.00519	CcSEcCtD
Mesalazine—Dermatitis—Metformin—metabolic syndrome X	0.000279	0.00518	CcSEcCtD
Mesalazine—Headache—Metformin—metabolic syndrome X	0.000277	0.00515	CcSEcCtD
Mesalazine—Salicylic acid—PTGS2—metabolic syndrome X	0.000264	0.0613	CrCbGaD
Mesalazine—Nausea—Metformin—metabolic syndrome X	0.000263	0.00489	CcSEcCtD
Mesalazine—Salicylic acid—ALB—metabolic syndrome X	0.000235	0.0546	CrCbGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—AKT1—metabolic syndrome X	3.23e-05	0.000202	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	3.22e-05	0.000201	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GCKR—metabolic syndrome X	3.19e-05	0.000199	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—LPA—metabolic syndrome X	3.19e-05	0.000199	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TRIB3—metabolic syndrome X	3.19e-05	0.000199	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—RBP4—metabolic syndrome X	3.19e-05	0.000199	CbGpPWpGaD
Mesalazine—PTGS2—Disease—G6PD—metabolic syndrome X	3.17e-05	0.000198	CbGpPWpGaD
Mesalazine—CHUK—B Cell Activation—AKT1—metabolic syndrome X	3.16e-05	0.000198	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—HMGCR—metabolic syndrome X	3.16e-05	0.000197	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—GOT2—metabolic syndrome X	3.16e-05	0.000197	CbGpPWpGaD
Mesalazine—CHUK—Disease—SLC2A4—metabolic syndrome X	3.15e-05	0.000197	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—PPARA—metabolic syndrome X	3.15e-05	0.000197	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—FABP4—metabolic syndrome X	3.14e-05	0.000196	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—IRS1—metabolic syndrome X	3.12e-05	0.000195	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—AKT1—metabolic syndrome X	3.1e-05	0.000194	CbGpPWpGaD
Mesalazine—CHUK—Immune System—VCAM1—metabolic syndrome X	3.1e-05	0.000194	CbGpPWpGaD
Mesalazine—PTGS2—Disease—HDAC3—metabolic syndrome X	3.09e-05	0.000193	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PLA2G6—metabolic syndrome X	3.09e-05	0.000193	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	3.07e-05	0.000192	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—APOA5—metabolic syndrome X	3.06e-05	0.000191	CbGpPWpGaD
Mesalazine—CHUK—Disease—GOT1—metabolic syndrome X	3.05e-05	0.000191	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—AGT—metabolic syndrome X	3.05e-05	0.000191	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—IL6—metabolic syndrome X	3.04e-05	0.00019	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—AKT1—metabolic syndrome X	3.03e-05	0.000189	CbGpPWpGaD
Mesalazine—PTGS2—Disease—GCKR—metabolic syndrome X	3.02e-05	0.000189	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—SIRT1—metabolic syndrome X	3.02e-05	0.000189	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—IRS1—metabolic syndrome X	3e-05	0.000187	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—APOE—metabolic syndrome X	2.99e-05	0.000187	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—HSD11B1—metabolic syndrome X	2.98e-05	0.000186	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	2.97e-05	0.000186	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MTNR1B—metabolic syndrome X	2.96e-05	0.000185	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—APOA1—metabolic syndrome X	2.96e-05	0.000185	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	2.91e-05	0.000182	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TRIB3—metabolic syndrome X	2.89e-05	0.000181	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—RBP4—metabolic syndrome X	2.89e-05	0.000181	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	2.89e-05	0.000181	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	2.88e-05	0.00018	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—AKT1—metabolic syndrome X	2.87e-05	0.000179	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	2.85e-05	0.000178	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—TRIB3—metabolic syndrome X	2.84e-05	0.000178	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—APOC3—metabolic syndrome X	2.82e-05	0.000176	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—ABCA1—metabolic syndrome X	2.81e-05	0.000176	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—SLC2A4—metabolic syndrome X	2.81e-05	0.000176	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—VCAM1—metabolic syndrome X	2.81e-05	0.000176	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	2.81e-05	0.000176	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	2.76e-05	0.000172	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	2.74e-05	0.000171	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL18—metabolic syndrome X	2.74e-05	0.000171	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—GOT1—metabolic syndrome X	2.73e-05	0.00017	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—GGT1—metabolic syndrome X	2.73e-05	0.00017	CbGpPWpGaD
Mesalazine—PTGS2—Disease—RBP4—metabolic syndrome X	2.7e-05	0.000169	CbGpPWpGaD
Mesalazine—PTGS2—Disease—TRIB3—metabolic syndrome X	2.7e-05	0.000169	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—NR3C1—metabolic syndrome X	2.68e-05	0.000167	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—G6PD—metabolic syndrome X	2.65e-05	0.000166	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	2.62e-05	0.000164	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—PPARG—metabolic syndrome X	2.6e-05	0.000163	CbGpPWpGaD
Mesalazine—CHUK—Disease—APOB—metabolic syndrome X	2.59e-05	0.000162	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—HDAC3—metabolic syndrome X	2.59e-05	0.000162	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—IL6—metabolic syndrome X	2.57e-05	0.000161	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	2.56e-05	0.00016	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—APOC3—metabolic syndrome X	2.56e-05	0.00016	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—INS—metabolic syndrome X	2.55e-05	0.00016	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—NAMPT—metabolic syndrome X	2.55e-05	0.000159	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—HTR2C—metabolic syndrome X	2.55e-05	0.000159	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD36—metabolic syndrome X	2.55e-05	0.000159	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	2.54e-05	0.000159	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GCK—metabolic syndrome X	2.53e-05	0.000158	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—LIPC—metabolic syndrome X	2.53e-05	0.000158	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GCKR—metabolic syndrome X	2.53e-05	0.000158	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—LPA—metabolic syndrome X	2.53e-05	0.000158	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—IL6—metabolic syndrome X	2.52e-05	0.000158	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—APOC3—metabolic syndrome X	2.52e-05	0.000157	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—PPARA—metabolic syndrome X	2.51e-05	0.000157	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL18—metabolic syndrome X	2.49e-05	0.000155	CbGpPWpGaD
Mesalazine—CHUK—Disease—LPL—metabolic syndrome X	2.48e-05	0.000155	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CYBA—metabolic syndrome X	2.47e-05	0.000154	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PLA2G6—metabolic syndrome X	2.45e-05	0.000153	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—CETP—metabolic syndrome X	2.45e-05	0.000153	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	2.44e-05	0.000152	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—APOA5—metabolic syndrome X	2.43e-05	0.000152	CbGpPWpGaD
Mesalazine—PTGS2—Disease—NAMPT—metabolic syndrome X	2.42e-05	0.000151	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—GHRL—metabolic syndrome X	2.41e-05	0.000151	CbGpPWpGaD
Mesalazine—PTGS2—Disease—GCK—metabolic syndrome X	2.4e-05	0.00015	CbGpPWpGaD
Mesalazine—PTGS2—Disease—APOC3—metabolic syndrome X	2.39e-05	0.000149	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	2.36e-05	0.000147	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—ALB—metabolic syndrome X	2.34e-05	0.000146	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—SCARB1—metabolic syndrome X	2.34e-05	0.000146	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—AKT1—metabolic syndrome X	2.33e-05	0.000146	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IL6—metabolic syndrome X	2.33e-05	0.000146	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—APOB—metabolic syndrome X	2.31e-05	0.000145	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	2.31e-05	0.000144	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—HTR2C—metabolic syndrome X	2.31e-05	0.000144	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD36—metabolic syndrome X	2.31e-05	0.000144	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—TGFB1—metabolic syndrome X	2.31e-05	0.000144	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CRP—metabolic syndrome X	2.3e-05	0.000144	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—IL6—metabolic syndrome X	2.29e-05	0.000143	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CNR1—metabolic syndrome X	2.29e-05	0.000143	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	2.28e-05	0.000143	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	2.28e-05	0.000143	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—SREBF1—metabolic syndrome X	2.27e-05	0.000142	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—TRIB3—metabolic syndrome X	2.26e-05	0.000141	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—PLA2G4A—metabolic syndrome X	2.25e-05	0.000141	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—NOS3—metabolic syndrome X	2.24e-05	0.00014	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CYBA—metabolic syndrome X	2.24e-05	0.00014	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—HMGCR—metabolic syndrome X	2.21e-05	0.000138	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GOT2—metabolic syndrome X	2.21e-05	0.000138	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—LPL—metabolic syndrome X	2.21e-05	0.000138	CbGpPWpGaD
Mesalazine—PTGS2—Disease—HMGA1—metabolic syndrome X	2.2e-05	0.000137	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—GHRL—metabolic syndrome X	2.19e-05	0.000137	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—TNF—metabolic syndrome X	2.15e-05	0.000135	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—AKT1—metabolic syndrome X	2.11e-05	0.000132	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—CD36—metabolic syndrome X	2.1e-05	0.000131	CbGpPWpGaD
Mesalazine—PTGS2—Disease—GOT2—metabolic syndrome X	2.1e-05	0.000131	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CYBA—metabolic syndrome X	2.09e-05	0.00013	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CRP—metabolic syndrome X	2.08e-05	0.00013	CbGpPWpGaD
Mesalazine—CHUK—Disease—APOE—metabolic syndrome X	2.07e-05	0.00013	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CNR1—metabolic syndrome X	2.07e-05	0.00013	CbGpPWpGaD
Mesalazine—CHUK—Disease—APOA1—metabolic syndrome X	2.05e-05	0.000128	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—PTGS2—metabolic syndrome X	2.05e-05	0.000128	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—NAMPT—metabolic syndrome X	2.02e-05	0.000127	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	2.01e-05	0.000126	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GCK—metabolic syndrome X	2.01e-05	0.000126	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—LIPC—metabolic syndrome X	2.01e-05	0.000126	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IRS1—metabolic syndrome X	2e-05	0.000125	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—APOC3—metabolic syndrome X	2e-05	0.000125	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	1.99e-05	0.000125	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—SLC2A4—metabolic syndrome X	1.97e-05	0.000123	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ABCA1—metabolic syndrome X	1.97e-05	0.000123	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—PPARA—metabolic syndrome X	1.95e-05	0.000122	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CETP—metabolic syndrome X	1.94e-05	0.000121	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GOT1—metabolic syndrome X	1.91e-05	0.000119	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GGT1—metabolic syndrome X	1.91e-05	0.000119	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	1.91e-05	0.000119	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—AGT—metabolic syndrome X	1.89e-05	0.000118	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IGF2—metabolic syndrome X	1.87e-05	0.000117	CbGpPWpGaD
Mesalazine—PTGS2—Disease—SLC2A4—metabolic syndrome X	1.87e-05	0.000117	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—SERPINE1—metabolic syndrome X	1.87e-05	0.000117	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—SCARB1—metabolic syndrome X	1.86e-05	0.000116	CbGpPWpGaD
Mesalazine—CHUK—Disease—IRS1—metabolic syndrome X	1.85e-05	0.000116	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—APOE—metabolic syndrome X	1.85e-05	0.000116	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—APOA1—metabolic syndrome X	1.83e-05	0.000114	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IRS1—metabolic syndrome X	1.82e-05	0.000114	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—APOB—metabolic syndrome X	1.82e-05	0.000113	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	1.81e-05	0.000113	CbGpPWpGaD
Mesalazine—PTGS2—Disease—GOT1—metabolic syndrome X	1.81e-05	0.000113	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—SREBF1—metabolic syndrome X	1.8e-05	0.000113	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CCL5—metabolic syndrome X	1.77e-05	0.000111	CbGpPWpGaD
Mesalazine—CHUK—Disease—INS—metabolic syndrome X	1.77e-05	0.000111	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.77e-05	0.00011	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—HMGCR—metabolic syndrome X	1.76e-05	0.00011	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GOT2—metabolic syndrome X	1.76e-05	0.00011	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—IL6—metabolic syndrome X	1.74e-05	0.000109	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—LPL—metabolic syndrome X	1.73e-05	0.000108	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IGF2—metabolic syndrome X	1.7e-05	0.000106	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—APOB—metabolic syndrome X	1.65e-05	0.000103	CbGpPWpGaD
Mesalazine—CHUK—Disease—SERPINE1—metabolic syndrome X	1.63e-05	0.000102	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—APOB—metabolic syndrome X	1.62e-05	0.000101	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCL5—metabolic syndrome X	1.61e-05	0.0001	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—AKT1—metabolic syndrome X	1.6e-05	0.0001	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.6e-05	0.0001	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—INS—metabolic syndrome X	1.58e-05	9.89e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PLA2G4A—metabolic syndrome X	1.58e-05	9.85e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—LPL—metabolic syndrome X	1.57e-05	9.83e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—SLC2A4—metabolic syndrome X	1.56e-05	9.78e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ABCA1—metabolic syndrome X	1.56e-05	9.78e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—NOS3—metabolic syndrome X	1.55e-05	9.72e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—LPL—metabolic syndrome X	1.55e-05	9.67e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—APOB—metabolic syndrome X	1.54e-05	9.6e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GGT1—metabolic syndrome X	1.52e-05	9.48e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GOT1—metabolic syndrome X	1.52e-05	9.48e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—AGT—metabolic syndrome X	1.48e-05	9.27e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—CD36—metabolic syndrome X	1.47e-05	9.19e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—LPL—metabolic syndrome X	1.47e-05	9.17e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—LEP—metabolic syndrome X	1.45e-05	9.08e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—APOE—metabolic syndrome X	1.45e-05	9.08e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—ALB—metabolic syndrome X	1.45e-05	9.06e-05	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—IL6—metabolic syndrome X	1.44e-05	9e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—APOA1—metabolic syndrome X	1.44e-05	8.98e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—PTGS2—metabolic syndrome X	1.42e-05	8.89e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—NOS3—metabolic syndrome X	1.39e-05	8.67e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PPARA—metabolic syndrome X	1.37e-05	8.54e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—AGT—metabolic syndrome X	1.34e-05	8.41e-05	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—AKT1—metabolic syndrome X	1.33e-05	8.31e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—AGT—metabolic syndrome X	1.32e-05	8.27e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—APOE—metabolic syndrome X	1.32e-05	8.24e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—LEP—metabolic syndrome X	1.32e-05	8.24e-05	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—IL6—metabolic syndrome X	1.31e-05	8.17e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—APOA1—metabolic syndrome X	1.3e-05	8.14e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—APOE—metabolic syndrome X	1.3e-05	8.11e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IRS1—metabolic syndrome X	1.3e-05	8.1e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—APOB—metabolic syndrome X	1.29e-05	8.04e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—APOA1—metabolic syndrome X	1.28e-05	8.01e-05	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—AKT1—metabolic syndrome X	1.28e-05	7.98e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—PTGS2—metabolic syndrome X	1.27e-05	7.93e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PLA2G4A—metabolic syndrome X	1.25e-05	7.82e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—INS—metabolic syndrome X	1.24e-05	7.76e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—APOE—metabolic syndrome X	1.23e-05	7.68e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—LPL—metabolic syndrome X	1.23e-05	7.68e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CCL2—metabolic syndrome X	1.22e-05	7.64e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—APOA1—metabolic syndrome X	1.21e-05	7.6e-05	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—AKT1—metabolic syndrome X	1.2e-05	7.53e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IGF1—metabolic syndrome X	1.2e-05	7.51e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IRS1—metabolic syndrome X	1.18e-05	7.35e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CD36—metabolic syndrome X	1.17e-05	7.29e-05	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—AKT1—metabolic syndrome X	1.16e-05	7.23e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—SERPINE1—metabolic syndrome X	1.14e-05	7.13e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PPARG—metabolic syndrome X	1.13e-05	7.06e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—INS—metabolic syndrome X	1.13e-05	7.04e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—INS—metabolic syndrome X	1.11e-05	6.92e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCL2—metabolic syndrome X	1.11e-05	6.92e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—IRS1—metabolic syndrome X	1.1e-05	6.85e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IGF1—metabolic syndrome X	1.09e-05	6.81e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—NOS3—metabolic syndrome X	1.09e-05	6.81e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PPARA—metabolic syndrome X	1.08e-05	6.78e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—AGT—metabolic syndrome X	1.05e-05	6.57e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—INS—metabolic syndrome X	1.05e-05	6.56e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—SERPINE1—metabolic syndrome X	1.03e-05	6.46e-05	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—AKT1—metabolic syndrome X	1.03e-05	6.44e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—APOE—metabolic syndrome X	1.03e-05	6.44e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—TGFB1—metabolic syndrome X	1.03e-05	6.43e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—APOA1—metabolic syndrome X	1.02e-05	6.36e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ALB—metabolic syndrome X	1.02e-05	6.35e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NOS3—metabolic syndrome X	9.87e-06	6.17e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—NOS3—metabolic syndrome X	9.71e-06	6.07e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—SERPINE1—metabolic syndrome X	9.64e-06	6.03e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—NOS3—metabolic syndrome X	9.21e-06	5.76e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PPARG—metabolic syndrome X	8.96e-06	5.61e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PTGS2—metabolic syndrome X	8.88e-06	5.55e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—INS—metabolic syndrome X	8.79e-06	5.5e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL6—metabolic syndrome X	8.39e-06	5.24e-05	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—AKT1—metabolic syndrome X	8.2e-06	5.12e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ALB—metabolic syndrome X	8.06e-06	5.04e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—IL6—metabolic syndrome X	7.74e-06	4.84e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—AKT1—metabolic syndrome X	7.74e-06	4.84e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—NOS3—metabolic syndrome X	7.71e-06	4.82e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL6—metabolic syndrome X	7.61e-06	4.76e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TGFB1—metabolic syndrome X	7.2e-06	4.5e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—AKT1—metabolic syndrome X	7.14e-06	4.47e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—AKT1—metabolic syndrome X	7.02e-06	4.39e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TGFB1—metabolic syndrome X	6.53e-06	4.08e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—AKT1—metabolic syndrome X	6.37e-06	3.99e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—TGFB1—metabolic syndrome X	6.09e-06	3.81e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IL6—metabolic syndrome X	5.42e-06	3.39e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—AKT1—metabolic syndrome X	5e-06	3.13e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IL6—metabolic syndrome X	4.92e-06	3.07e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—IL6—metabolic syndrome X	4.59e-06	2.87e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—AKT1—metabolic syndrome X	4.54e-06	2.84e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—AKT1—metabolic syndrome X	4.46e-06	2.79e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—AKT1—metabolic syndrome X	4.23e-06	2.65e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—AKT1—metabolic syndrome X	3.54e-06	2.22e-05	CbGpPWpGaD
